Holly Wang

 Work with the marketing department to develop marketing strategies and materials.  Work closely with the medical information teams to make sure that information about all the company's products are available and current.  Develop clinical research proposal and review investigator initiated study materials.  Regular communication with KOLs to share most updated medical information and maintain the relationship in the defined therapeutic areas

CV-Medical Advisor

Scientific Expertise ( internal) : 1. Maintains clinical/scientific expertise in disease state management, AZ brands, emerging therapies, and the competitive landscape. 2. Demonstrates leadership and management qualities within and across Field team and Therapeutic Area. 3. Acts as a subject matter expert/resource for internal customers. • Scientific Exchange (external): 1. Engages in target KOLs deliver appropriate clinical/scientific information specific to AstraZeneca’s products and relevant therapeutic area . 2. Responds to unsolicited customer inquiries and provide focused and balanced clinical / scientific information that supports the safe and appropriate use of AstraZeneca’s products. 3. Provides scientific/clinical support and deliver data presentations for target KOLs 4. KOL identification and KOL engagement with Astrazeneca’s products and compounds in development and TA new progress 5. Lead non-promotional scientific meeting to delivery new progress on product related therapeutic area.

1. Copy review for medical or product materials, including Diabetes, Cardiovascular, Sterilization and Diagnosis devices. 2. Translate product/medical related reference, summarize and compile to a leaflet. 3. Provide medical support to sales and market group in Cardiovascular Units. 4. SAE report, IFU, Cinical Study Report revise in Cardiovascular Units. 5. Assist in IIS processing, including reference update, study design and communicate with global JNJ and HCP in cardiovascular aspect. 6. Help building and maintaining customer relationships through professional interactions, such as inviting international expert to give presentations to local HCPs, update disease related references.

1. Assist Beta pharma induced type 2 diabetic, hyperglycemia rat/or models and evaluate drug efficiency. 2. Set up bleomycin induced pulmonary fibrosis mouse model and observed the pathological changes in lung and inflammation factors in plasma. 3. Collaborate with Pfizer for 4 drug efficiency studies. 4. Use KKAY transgene mice under hyperglycemia to observe multiple organ complications.

1. Major in diabetes, hypertriglyceridemia and atherosclerosis. 2. Collaborate with Otsuka Pharmaceutical Group to evaluate antiplatelet drug efficiency.